Recombinant Anti-human HTT Intrabody [Tat]

Recombinant anti-HTT intrabody in fusion with HIV Tat works within cells and is directed against htt and prevent aggregation, show promise as immunotherapeutics for HD, expressed in 293T cells. The anti-huntingtin intrabody can degrade mutant huntingtin proteins by directing them to the proteasome, while also increasing the negative charge.
Supplier Creative Biolabs
Product # IAB-B023(T)
Pricing Inquiry
Host human
Target HTT
Species Reactivity human
Type scFv-Tat
Applications Formats of immunological tests: Western blot; Coimmunopricipation; Functional studies
Storage Store at -20°C. Open under aseptic conditions.
Feedback